The significant increase in rates of HER2 positivity after completing FISH testing on IHC 0 or 1+ suggests that there may be a role for routine FISH testing in addition to standard IHC staining to determine HER2 status for breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.